BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28625001)

  • 1. Nanostructured SBA-15 host applied in ketorolac tromethamine release system.
    Cussa J; Juárez JM; Gómez Costa MB; Anunziata OA
    J Mater Sci Mater Med; 2017 Aug; 28(8):113. PubMed ID: 28625001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
    Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
    Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ordered mesoporous silica material SBA-15: loading of new calcium channel blocker--lacidipine.
    Kiwilsza A; Mielcarek J; Pajzderska A; Wąsicki J
    J Microencapsul; 2013; 30(1):21-7. PubMed ID: 22676483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
    Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
    Yang P; Huang S; Kong D; Lin J; Fu H
    Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology.
    Hashemikia S; Hemmatinejad N; Ahmadi E; Montazer M
    J Colloid Interface Sci; 2015 Apr; 443():105-14. PubMed ID: 25540827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of carboxyl-modified rod-like SBA-15 by rapid co-condensation.
    Shen S; Chow PS; Kim S; Zhu K; Tan RB
    J Colloid Interface Sci; 2008 May; 321(2):365-72. PubMed ID: 18328495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
    Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
    Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
    Maleki A; Hamidi M
    Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modified SBA-15 mesoporous silica for heavy metal ions remediation.
    Mureseanu M; Reiss A; Stefanescu I; David E; Parvulescu V; Renard G; Hulea V
    Chemosphere; 2008 Nov; 73(9):1499-504. PubMed ID: 18760443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity study and influence of SBA-15 surface polarity and pH on adsorption and release properties of anticancer agent pemetrexed.
    Almáši M; Beňová E; Zeleňák V; Madaj B; Huntošová V; Brus J; Urbanová M; Bednarčík J; Hornebecq V
    Mater Sci Eng C Mater Biol Appl; 2020 Apr; 109():110552. PubMed ID: 32228921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
    Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery.
    Ahmadi E; Dehghannejad N; Hashemikia S; Ghasemnejad M; Tabebordbar H
    Drug Deliv; 2014 May; 21(3):164-72. PubMed ID: 24116869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
    Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
    J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amine bridges grafted mesoporous silica, as a prolonged/controlled drug release system for the enhanced therapeutic effect of short life drugs.
    Rehman F; Ahmed K; Airoldi C; Gaisford S; Buanz A; Rahim A; Muhammad N; Volpe PLO
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():34-41. PubMed ID: 28024595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development, evaluation and pharmacokinetics of time-dependent ketorolac tromethamine tablets.
    Vemula SK; Veerareddy PR
    Expert Opin Drug Deliv; 2013 Jan; 10(1):33-45. PubMed ID: 23199134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization, and evaluation in vivo of Ins-SiO₂-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin.
    Zhao X; Shan C; Zu Y; Zhang Y; Wang W; Wang K; Sui X; Li R
    Int J Pharm; 2013 Sep; 454(1):278-84. PubMed ID: 23830939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adsorption and release of ampicillin antibiotic from ordered mesoporous silica.
    Nairi V; Medda L; Monduzzi M; Salis A
    J Colloid Interface Sci; 2017 Jul; 497():217-225. PubMed ID: 28285049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-dimensional ultralarge-pore ia3d mesoporous silica with various pore diameters and their application in biomolecule immobilization.
    Vinu A; Gokulakrishnan N; Balasubramanian VV; Alam S; Kapoor MP; Ariga K; Mori T
    Chemistry; 2008; 14(36):11529-38. PubMed ID: 19006167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
    Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
    J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.